CH Biotech R&D Co., Ltd.
TPEX:6534
NT$ 91.60
+ NT$1.70 (1.89%)
NT$ 91.60
+ NT$1.70 (1.89%)
End-of-day quote: 05/14/2024

6534 - CH Biotech R&D Stock Prediction 2025 - 2030

9 years of reliable CH Biotech R&D stock forecast. The Wall Street analysts predict Hold for 6534. See at a glance whether TPEX:6534 will rise in the future.

NT$145.87
Forecast 2023
NT$114.52
Forecast 2025
NT$129.93
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
NT$145.87
Forecast 2025
NT$114.52
Forecast 2030
NT$129.93
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
0.43
Price-to-book Ratio
3.57
Market Cap
9.42B
TEV
9.30 B
Dividend
NT$4.17
Div Yld
4.55%
Forecast 1Y
87.53%
Forecast 2Y
0.00%
Analyst Price Target
NT$0.00
Country

CH Biotech R&D Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

CH Biotech R&D Stock Forecast 2023

NT$89.00

In the last five quarters, CH Biotech R&D’s Price Target has risen from NT$0.00 to NT$91.60 - a 100% increase. One analysts predict that CH Biotech R&D’s share price will fall in the coming year, reaching NT$89.00. This would represent a decrease of -2.84%.

-2.84%
-2.84
Last update: 05/15/2024

Highest Price Target NT$89.00

Average Price Target NT$89.00

Lowest Price Target NT$89.00

CH Biotech R&D Stock Prediction 2025

CH Biotech R&D Stock Predictions for Jan 2025.

In January 2025 analysts predict a stock price of NT$167.01. An increase of 82.32% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Feb 2025.

In February 2025 analysts predict a stock price of NT$162.24. An increase of 77.11% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Mar 2025.

In March 2025 analysts predict a stock price of NT$157.46. An increase of 71.9% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Apr 2025.

In April 2025 analysts predict a stock price of NT$152.69. An increase of 66.69% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for May 2025.

In May 2025 analysts predict a stock price of NT$147.92. An increase of 61.49% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Jun 2025.

In June 2025 analysts predict a stock price of NT$143.15. An increase of 56.28% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Jul 2025.

In July 2025 analysts predict a stock price of NT$138.38. An increase of 51.07% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Aug 2025.

In August 2025 analysts predict a stock price of NT$133.61. An increase of 45.86% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Sep 2025.

In September 2025 analysts predict a stock price of NT$128.83. An increase of 40.65% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Oct 2025.

In October 2025 analysts predict a stock price of NT$124.06. An increase of 35.44% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Nov 2025.

In November 2025 analysts predict a stock price of NT$119.29. An increase of 30.23% compared to the previous month's estimate.

CH Biotech R&D Stock Predictions for Dec 2025.

In December 2025 analysts predict a stock price of NT$114.52. An increase of 25.02% compared to the previous month's estimate.

CH Biotech R&D Stock Forecast 2030

Stock Forecast for the Price of an CH Biotech R&D Share in Jan 2030.

In January 2030, analysts believe the stock price will be NT$125.57. An increase of 37.08% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Feb 2030.

In February 2030, analysts believe the stock price will be NT$125.96. An increase of 37.51% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Mar 2030.

In March 2030, analysts believe the stock price will be NT$126.36. An increase of 37.95% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Apr 2030.

In April 2030, analysts believe the stock price will be NT$126.75. An increase of 38.38% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in May 2030.

In May 2030, analysts believe the stock price will be NT$127.15. An increase of 38.81% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Jun 2030.

In June 2030, analysts believe the stock price will be NT$127.55. An increase of 39.24% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Jul 2030.

In July 2030, analysts believe the stock price will be NT$127.94. An increase of 39.68% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Aug 2030.

In August 2030, analysts believe the stock price will be NT$128.34. An increase of 40.11% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Sep 2030.

In September 2030, analysts believe the stock price will be NT$128.74. An increase of 40.54% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Oct 2030.

In October 2030, analysts believe the stock price will be NT$129.13. An increase of 40.97% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Nov 2030.

In November 2030, analysts believe the stock price will be NT$129.53. An increase of 41.41% compared to the previous month's estimate.

Stock Forecast for the Price of an CH Biotech R&D Share in Dec 2030.

In December 2030, analysts believe the stock price will be NT$129.93. An increase of 41.84% compared to the previous month's estimate.

P/E
0.00
Beta
0.43
Price-to-book Ratio
3.57
Market Cap
9.42B
TEV
9.30 B
Dividend
NT$4.17
Div Yld
4.55%
Forecast 1Y
87.53%
Forecast 2Y
0.00%
Analyst Price Target
NT$0.00
Country

CH Biotech R&D Analyst Ratings Frequently Asked Questions

Who are the analysts watching CH Biotech R&D Co., Ltd.?

The following analysts have recently covered CH Biotech R&D:

Capital Securities Corporation
Masterlink Securities Corp.
(This information refers to the last 90 days.)

Who are the sell-side analysts watching CH Biotech R&D Co., Ltd.?

The following sell-side analysts have recently covered CH Biotech R&D:

Kuo, Yenya
Lin, Hsiu Chi
(This information refers to the last 90 days.)